[1] |
ZHANG Shiyi, SUN Jiamin, ZHONG Jianhong, WANG Qiuyan, TAO Yuting.
Clinical significance of YAP signaling activation in extracellular matrix remodeling in hepatocellular carcinoma and its molecular mechanisms
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 30-39.
|
[2] |
LI Meng, LI Pingchuan, LIU Xiaoqiang, YANG Huawei.
Effects of MCM5 knockdown on proliferation,migration and apoptosis of breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 40-47.
|
[3] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
[4] |
ZHANG Yuanfen, LONG Ying, YAO Desheng.
Relationship between perineural invasion,clinical pathological characteristics of cervical cancer and its effects on prognosis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 109-114.
|
[5] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
[6] |
AN Yanxiao, JIAO Hanliang, QI Yanwei, ZHONG Zhiyong.
Effects of lncRNA PSMA3-AS1 on proliferation,migration and invasion of neuroblastoma cells by regulating the miR-186?5p/SOX4 axis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 715-721.
|
[7] |
JIANG Yuan, WANG Xiaoyan, LEI lei, LIU Lihua, WU Danfeng, ZHANG Siqi, TANG Dairong, FAN Lingli, FENG Gang, XUE Xiaojing.
Summary of the best evidence for blood glucose management in cancer patients with immune checkpoint inhibitors inducing hyperglycemia
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 722-728.
|
[8] |
HUANG Shihuan, LAN Huiyu, NONG Xiaolian, LI Fanrong, ZHAO Fengjuan, YOU Xuemei.
Network analysis of concurrent symptoms and core symptom identification in patients with intermediate and advanced hepatocellular carcinoma after surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 729-735.
|
[9] |
WANG Huijuan, CHEN Wenming, GENG Chuanying, YANG Guangzhong .
Clinical characteristics of patients with relapsed/refractory multiple myeloma after CAR-T cell therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 549-553.
|
[10] |
LIANG Yuanzheng, WANG Henan, WANG Liang.
Effects of PPP2R5C on proliferation, apoptosis, and drug sensitivity of multiple myeloma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 405-411.
|
[11] |
TANG Min, HUANG Juanchan, WEI Xingwen, LUO Xuewen, ZHAO Wei .
Effects of disulfiram combined with Cu2+ induced cuproptosis on proli-feration,migration and invasion of hepatoma Hep3B cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 417-423.
|
[12] |
LIANG Si, SHENG Yonghong, LIU Shun, LIU Meiliang, YANG Yu, LEI Lei, WU Lili, ZENG Xiaoyun.
Gene expression profiling of peripheral blood B cells before and after surgery for hepatocellular carcinoma based on single-cell RNA sequencing technology
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 433-.
|
[13] |
ZHANG Siyi, HUANG Xiangyang, QIN Yunying, LIU Lijuan, HUANG Caiyun, LUO Ningbin.
Preoperative CT signs combined with clinical indicators predict the expression of cytokeratin 19 in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 461-467.
|
[14] |
CHEN Shunqi, LIU Xinyi, ZENG Tao, LIU Mengyu, WANG Yuting, XIN Haibei, LI Yuanfeng, ZHOU Gangqiao#br#.
TM6SF1 affects the biological behavior of intrahepatic cholangiocarcinoma cells by inhibiting the KRAS-MEK-ERK signaling pathway
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 261-270.
|
[15] |
YAN Haiqing, LAI Qinqiao, WU Liucheng, WANG Ting'an, XIA Xiang, HUANG Mingwei, QIN Yuzhou.
Effects of SH3BGRL on proliferation and migration of gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 285-294.
|